Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00496210 · ClinicalTrials.gov registry record
Predictors of Caregiver Adaptation to Pervasive Developmental Disorders
A clinical trial of Autism and Asperger's Syndrome, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 324
- Enrollment target
- 1
- Study location
NCT00496210 is a study of Autism and Asperger's Syndrome that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 324 participants, above the 180-participant average among 104 other Autism trials with a reported enrollment target (80% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00496210, a study of Autism and Asperger's Syndrome, has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 324 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will explore predictors of how caregivers might adapt to children diagnosed with a pervasive developmental disorder (PDD), including autism, Asperger s syndrome, childhood disintegrative disorder, Rett s disorder or other not specified PDD. PDD presents particular challenges for caregivers because of the communication and socialization challenges of affected children and because of the uncertainty surrounding the cause, prognosis and recurrence risks. People 18 years of age or older who are the primary caregiver for a child diagnosed with a PDD may be eligible for this study. Participants fill out a survey, either online or in hard copy, that includes information in the following categories: * How being a caregiver for a child with a PDD has impacted the caregiver. * How much control the caregiver feels that he or she or others have over certain aspects of their child s PDD. * What the caregiver thinks caused the child s PDD. * What coping techniques the caregiver uses in caring for a child with a PDD. * How uncertain the caregiver feels about his or her child s PDD. * What the caregiver feels about him- or herself as a caregiver of a child with a PDD. * General questions about the caregiver, his or her family and the child with a PDD.
Conditions Studied
Study Locations (1)
Maryland
- National Human Genome Research Institute (NHGRI), 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2007-06-27 |
| Est. Completion | 2015-12-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00496210
The ClinicalTrials.gov registry entry for NCT00496210 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 324 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 180-participant average among 104 other Autism trials with a reported enrollment target (80% higher). The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Autism appearing as the primary indexed condition, and to 0 interventions.
NCT00496210 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00496210 about?
NCT00496210 is a clinical study titled "Predictors of Caregiver Adaptation to Pervasive Developmental Disorders". This study will explore predictors of how caregivers might adapt to children diagnosed with a pervasive developmental disorder (PDD), including autism, Asperger s syndrome, childhood disintegrative disorder, Rett s disorder or other not specified PDD. PDD presents particular challenges for caregiver...
What is the current status of trial NCT00496210?
This trial is currently completed. The enrollment target is 324 participants. The study started on 2007-06-27. Estimated completion is 2015-12-07.
What conditions does trial NCT00496210 study?
This clinical trial studies the following conditions: Autism, Asperger's Syndrome, Rett's Disorder.
Who is sponsoring clinical trial NCT00496210?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00496210 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Optimizing Outcomes for Young Autistic Children
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.